ResMed (RMD) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 61.5%
EBITDA Margin: 35.0%
Op. Margin: 32.0%
Net Margin: 29.6%

Op. margin of 32.0% is down 1.4% YoY — costs are rising relative to revenue. Net margin at 29.6% and gross margin of 61.5% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit